Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
"Capital One $425M settlement approved
Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition
Customer support We were happy to have received an initial response within 24 hours of our inquiry, but the message told us only that someone else would get back to us eventually
S2CID 23096987
US$ 22.54
.jpeg?w=1500&h=1000)
US$ 29.33
US$ 27.39
US$ 23.58
